Experimental lymphedema drug reduces swelling in clinical trials in new hope for patients

Scientists have inched a step closer to developing a first-of-its-kind drug to treat lymphedema, a chronic swelling condition that affects 10 million Americans.

Dumpster Fire links to reporting from Daily Mail. We don’t rewrite the facts; the original story is one click away.